BBusiness Read More Sonnet BioTherapeutics, Inc. Announces $888 MillionJuly 14, 2025 PRINCETON, N.J., July 14, 2025 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics, Inc., (NASDAQ: SONN) (“Sonnet” or the “Company”) today…